Patel Naimish sold CRSP
March 16, 2026 · Form 4 insider transaction
Patel Naimish sold 3,150 shares of CRISPR Therapeutics AG at $48.26 per share, a transaction worth $152.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,150
Price
$48.26
Total value
$152.0K
InsiderPatel Naimish
RoleOfficer
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after13,143
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.